NE Property (A3K1DD)

Play Episode

5min

Proactive - Interviews for investors

The Vaccine Group teams up with animal health giant Syva on breakthrough pig vaccine

Jeremy Salt, CEO of The Vaccine Group (TVG), a Frontier IP Group PLC portfolio company, talked with Proactive's Stephen Gunnion about the company’s collaboration with global animal health firm Syva. Salt explained that the partnership focuses on developing a vaccine for Streptococcus suis, a major disease in pigs that also contributes significantly to the use of antibiotics in livestock farming. “One of the key aspects of this collaboration with them is that they have a significant gap in their portfolio of products for pigs,” Salt noted. He emphasised that Streptococcus suis is prevalent in around 60% of European countries and impacts pig farming worldwide, with antimicrobial resistance (AMR) being a critical concern. The zoonotic nature of the disease, particularly in Southeast Asia, adds another layer of urgency to develop effective solutions. Salt highlighted that TVG’s vaccine platform provides broader protection across multiple strains, making it potentially globally applicable. The vaccine can be administered to young piglets, which is strategically important and is also expected to be more cost-effective than conventional options. He also discussed the role of UK government support, with Innovate UK and DEFRA grants contributing around £1 million in funding. The company is also progressing with 12 vaccine candidates, including developments in poultry and biotherapeutics delivery using monoclonal antibodies. For more updates, visit Proactive's YouTube channel. Don't forget to like the video, subscribe to the channel, and turn on notifications for future content. #AnimalHealth #Vaccines #SwineIndustry #AntimicrobialResistance #BiotechNews #TVG #FrontierIP #ProactiveInvestors #PigHealth #ZoonoticDiseases #LivestockFarming #VeterinaryInnovation #MonoclonalAntibodies #PoultryVaccines #Biotherapeutics

Proactive - Interviews for investors

Tariffs, steel & strategy: Diales CEO Mark Wheeler speaks

Diales Group PLC (LON:DIAL) CEO Mark Wheeler talked with Proactive's Stephen Gunnion about the company’s global operations and how it supports clients across the engineering and construction sectors—particularly with dispute resolution, cost escalation claims, and complex project planning. Wheeler explained that Diales works with major contractors, joint ventures, government bodies, and clients across infrastructure, energy, and offshore projects. He said, “We support them with their contracts, planning, programming and claims and dispute resolution,” highlighting the company's niche expertise in large-scale, often novel engineering environments. In light of new US tariffs on steel and aluminum, Wheeler said Diales is seeing increased client inquiries and is well-positioned to provide strategic guidance. He noted the company’s experience with “cost escalation claims” and emphasised the value of early contractual advice to manage such risks. He also discussed supply chain challenges, especially where key components are manufactured globally. “One or two small components can really delay the delivery and completion of the construction of some quite significant pieces of equipment,” Wheeler noted. Finally, Wheeler addressed the ongoing share buyback program, which he described as popular with shareholders. He reiterated the company's belief that it is currently “the best value stock to be buying,” particularly given AIM market illiquidity. For more interviews like this one, visit Proactive's YouTube channel. Don’t forget to like this video, subscribe to our channel, and turn on notifications to stay updated on future content. #DialesGroup #EngineeringDisputes #ConstructionSector #GlobalInfrastructure #ShareBuyback #AIMMarket #CostEscalation #SupplyChainIssues #SteelTariffs #MarkWheeler #ConstructionLaw #EnergyProjects #ProactiveInvestors

Proactive - Interviews for investors

Futura Medical CEO James Barder on Futura’s 2024 strong growth, maiden profit and 2025 plans

Futura Medical PLC CEO James Barder takes Proactive's Stephen Gunnion through the company’s 2024 financial performance, market expansion and product pipeline. Futura reported a strong year in 2024, with CEO Barder highlighting revenue of £14 million and a maiden profit of £1.3 million—or £3.3 million excluding non-cash items. Barder noted that Eroxon is now sold in over 15 countries and is expected to reach over 20 by the end of 2025. “2024 was a very good year for us,” he said. Barder emphasised the company’s commitment to supporting commercial partners and building momentum behind its flagship product, Eroxon. He explained that markets seeing the most success were those effectively targeting men under 60 with mild to moderate erectile dysfunction—Eroxon’s most responsive user group. The conversation also touched on upcoming products, including Eroxon Intense, a variant delivering a stronger sensory experience, and SD4000, a topical treatment for female sexual dysfunction. Barder noted that 87% of women in clinical trials for SD4000 wished to continue use post-study—an encouraging sign. Looking ahead, Barder said the company will continue expanding its presence, drive forward its pipeline, and focus on areas it can control, despite share price frustrations. For more interviews like this, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe to our channel, and hit the bell icon for updates. #FuturaMedical #Eroxon #EroxonIntense #SD4000 #ErectileDysfunction #FemaleHealth #PharmaNews #OTCProducts #HealthcareInnovation #BiotechUpdate

Proactive - Interviews for investors

Quartix sees record subscription growth after strategic refocus under returning founder

Quartix Technology Plc Executive Chairman Andy Walters joined Steve Darling from Proactive to highlight the company’s recent momentum following his return to leadership in 2023. Walters credited renewed focus on core software capabilities and customer acquisition strategies for driving strong performance, especially in subscription revenue growth. “When I came back to the business, we grew the value of the subscription base by about £2 million,” Walters explained. “Last year, that grew by £3.5 million, and in Q1 of this year alone, it increased by £2 million.” Founded in 2001, Quartix provides a subscription-based vehicle tracking service tailored for light commercial vehicles. Its core market includes small- to medium-sized businesses in industries such as construction, HVAC, and plumbing—segments more interested in stationary vehicle insights and utilization data rather than real-time logistics tracking. Walters noted the company’s competitive edge lies in its simplicity and focus—delivering high-value insights for customers who rely on small vehicle fleets for day-to-day operations. He also addressed manufacturing cost pressures, which had risen during the inflationary period. Quartix has since introduced a new hardware version that has helped reduce costs, setting the stage for improved gross margins in the coming fiscal year. In the interim, savings are already being reinvested to support enhanced marketing and sales initiatives. Today, Quartix supports around 310,000 vehicles across 30,000 customers in six countries, a footprint Walters sees as strong validation of the company’s specialized approach in a crowded telematics space. #proactiveinvestors #lse #qtx #gbx #FleetManagement #AndyWalters #TechInnovation #BusinessGrowth #SubscriptionRevenue #CostEfficiency #UKTech #LightCommercialVehicles #ProactiveInvestors #ExecutiveInterview

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Latest A3K1DD Trades

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

NE Property (A3K1DD) Trades